MAGENTIQ Eye Secures Series A Funding for AI-powered Gastroenterology Innovation

Deal News | Jul 30, 2025 | PR Newswire Cision MAGENTIQ-EYE LTD.

MAGENTIQ EYE LTD, an Israeli innovator in AI-driven gastroenterology, has successfully secured Series A funding led by aMoon, Israel's largest healthcare technology investment fund. The funds will be used to commercialize their AI-aided colonoscopy solution, MAGENTIQ-COLO™, in the US and Europe. Recognized by the global gastroenterology community, MAGENTIQ EYE's software has received FDA and CE approval, enhancing polyp detection during colonoscopies. The funding round also sees contributions from Norgine Ventures BV, Nina Capital, Namarel Ventures SL, and Nova Capital, as well as private investors Sake Bosch and Roon Doornink. With this investment, Roy Wiesner from aMoon will join the board of MAGENTIQ EYE. The company plans to accelerate its market entry and innovation efforts, while continuing clinical trials on diagnostic tools for various gastrointestinal diseases.

Sectors

  • Healthcare Technology
  • Venture Capital

Geography

  • Israel – MAGENTIQ EYE is based in Haifa, Israel, and the leading investor aMoon is also an Israeli venture capital fund.
  • United States – The funding will be used to support commercialization efforts in the United States.
  • Europe – The article mentions expansion and commercialization efforts in Europe.

Industry

  • Healthcare Technology – The article discusses MAGENTIQ EYE's AI-aided colonoscopy solution within the healthcare sector.
  • Venture Capital – The Series A funding round led by venture capital fund aMoon is a primary focus.

Financials

  • $1.3 billion – The total asset under management by aMoon fund.

Participants

NameRoleTypeDescription
MAGENTIQ EYE LTDTarget CompanyCompanyAn Israeli firm specializing in AI-driven gastroenterology solutions.
aMoonLead InvestorCompanyIsrael’s largest healthcare technology investment fund, leading the Series A round.
Norgine Ventures BVInvestorCompanyParticipated in the funding round, based in the Netherlands.
Nina CapitalInvestorCompanyA Europe and US-based investor involved in the funding.
Namarel Ventures SLInvestorCompanySpanish venture capital firm participating in the funding.
Nova CapitalInvestorCompanyItalian investment firm contributing to the funding.
Roy WiesnerBoard MemberPersonPartner at aMoon joining the MAGENTIQ EYE board.
Dror Zur, Ph.D.CEO and FounderPersonFounder and CEO of MAGENTIQ EYE LTD.
Sake BoschPrivate InvestorPersonIndividual investor from the United States.
Roon DoorninkPrivate InvestorPersonIndividual investor from the United States.